LDL Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: EMERGING INSIGHTS

April 08, 2017

In this program, Dr. Lynn Braun and Dr. Michael Miller present lectures and case studies addressing the management of atherosclerotic cardiovascular disease along with best practices and treatment options.

CE | CME 1.00 Credits

The Perfect Storm of Heart Failure and Diabetes: Insights into Pathophysiology and Evidence-Based Treatment Strategies

November 08, 2016

In this educational initiative, experts will address the needs of cardiologists for 1) a grasp of the relationship between DM and HF and the pathophysiology of HF in DM, 2) an explanation of clinical evidence for HF drugs in patients with DM, and 3) an assessment of the profiles of traditional and newer antidiabetic agents in patients with/at risk for cardiovascular disease and interpretation of heart failure-related outcomes.

CME 1.00 Credits

Optimizing Management of Recurrent Angina after PCI

May 08, 2015

Deepak Bhatt, MD, MPH, FSCAI (Chair); Duane Pinto, MD, FSCAI and Peter Stone, MD, MPH conduct a state-of-the-art discussion and case study on recurrent angina after PCI

No Credit Available

Demystifying Hypertriglyceridemia: Taking a Closer Look at Pathophysiology, Etiology, and Treatment

April 29, 2015

Eliot Brinton, MD and Terry Jacobson, MD discuss the pathophysiology, etiology, and treatment of hypertriglyceridemia.

No Credit Available

The Dynamics of In-Hospital and Post-Discharge ACS Management with Oral Antiplatelet Therapies

March 14, 2015

Jeffrey Anderson, MD, Van de Werf,MD and Marc Sabatine MD, discuss timing/location, dosing, duration of oral antiplatelet therapies, clinical trials, and guidelines.

No Credit Available

New Pathways to GLYCEMIC CONTROL: Focus on the Kidney

October 28, 2014

Presentations by Jay Shubrook, DO (Chair), Eugene Cersosimo, MD, PhD, and Robert Henry, MD. discussing the role of glucose regulation and SGLT 2 inhibitors in antihyperglycemic therapy

No Credit Available

Oral Antiplatelet Therapies for Acute Coronary Syndromes: State of the Art Management

September 15, 2014

Deepak Bhatt, MD, MPH (Chair), Paul Gurbel, MD, Robert Harrington, MD, Ajay Kirtane, MD, SM, Manesh Patel, MD, Marc Sabatine, MD, MPH and Philippe Gabriel Steg, MD discuss contemporary use of antiplatelet therapy and ACS management in lectures and cases.

No Credit Available

From Clinical Trials to Clinical Practice: Optimizing Outcomes with Oral Antiplatelet Therapies in Acute Coronary Syndromes

March 30, 2014

This presentation was filmed as a Roundtable discussion and chaired by Christopher Cannon, MD. The expert panel included Deepak Bhatt, MD, MPH, James De Lemos, MD, and Roxana Mehran, MD

No Credit Available